Results 271 to 280 of about 62,795 (319)
Some of the next articles are maybe not open access.
Current Treatment Options in Oncology, 2018
Polycythemia vera (PV) is the most common myeloproliferative neoplasm (MPN), the ultimate phenotype of the JAK2 V1617F mutation, the MPN with the highest incidence of thromboembolic complications, which usually occur early in the course of the disease, and the only MPN in which erythrocytosis occurs. The classical presentation of PV is characterized by
Jerry L. Spivak
openaire +3 more sources
Polycythemia vera (PV) is the most common myeloproliferative neoplasm (MPN), the ultimate phenotype of the JAK2 V1617F mutation, the MPN with the highest incidence of thromboembolic complications, which usually occur early in the course of the disease, and the only MPN in which erythrocytosis occurs. The classical presentation of PV is characterized by
Jerry L. Spivak
openaire +3 more sources
Journal of Urology, 2022
Purpose: An unsafe hematocrit threshold for men receiving testosterone therapy (TT) has never been tested. This study seeks to determine whether secondary polycythemia among men receiving TT confers an increased risk of major adverse cardiovascular ...
J. Ory +4 more
semanticscholar +1 more source
Purpose: An unsafe hematocrit threshold for men receiving testosterone therapy (TT) has never been tested. This study seeks to determine whether secondary polycythemia among men receiving TT confers an increased risk of major adverse cardiovascular ...
J. Ory +4 more
semanticscholar +1 more source
Polycythemia in the newborn [PDF]
The Indian Journal of Pediatrics, 2008 Polycythemia is defined as a venous hematocrit of over 65%. The hematocrit in a newborn peaks at 2 hours of age and decreases gradually after that. The etiology of polycythemia is related either to intra-uterine hypoxia or secondary to fetal transfusion.
M. Jeevasankar +4 more
openaire +2 more sources
Hydronephrosis and polycythemia
Urology, 1983Polycythemia is consistently produced in animals undergoing experimental hydronephrosis. This hematologic response is thought to be mediated by a microcirculatory insult and a more accelerated elaboration of erythropoietin by the hydronephrotic kidney.
Irvin Hirsch, Elliot Leiter
openaire +3 more sources
MCN, The American Journal of Maternal/Child Nursing, 2003
Neonatal polycythemia, a venous hematocrit >65%, occurs in 1% to 5% of the total newborn population. Polycythemia can result from an excess production of red blood cells (active form) or from an increase in fetal blood volume (passive form). Clinical manifestations of polycythemia are caused by an increase in whole blood viscosity with a subsequent ...
Valerie Huseby +2 more
openaire +3 more sources
Neonatal polycythemia, a venous hematocrit >65%, occurs in 1% to 5% of the total newborn population. Polycythemia can result from an excess production of red blood cells (active form) or from an increase in fetal blood volume (passive form). Clinical manifestations of polycythemia are caused by an increase in whole blood viscosity with a subsequent ...
Valerie Huseby +2 more
openaire +3 more sources
JAMA, 1964
COMPOUND 8103-Abbott (A-8103), a neutral amide of piperazine (NSC-25154), 1, 4-bis (3-bromopropronyl) piperazine, was shown to have a favorable effect upon neoplastic disease including polycythemia rubra vera by Bond et al in 1962.1The antitumor properties of the neutral amide were first demonstrated in transplanted adenocarcinoma, Ca 755 in mice, and ...
John D. Battle +5 more
openaire +3 more sources
COMPOUND 8103-Abbott (A-8103), a neutral amide of piperazine (NSC-25154), 1, 4-bis (3-bromopropronyl) piperazine, was shown to have a favorable effect upon neoplastic disease including polycythemia rubra vera by Bond et al in 1962.1The antitumor properties of the neutral amide were first demonstrated in transplanted adenocarcinoma, Ca 755 in mice, and ...
John D. Battle +5 more
openaire +3 more sources